📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-01 11:33
343 analysed today
343
Today
133,232
All-time analysed
40,094
Positive
6,279
Negative
79,048
Neutral
7,743
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
6 announcements match the current filters (relevance ≥ 5).
Vipul Organics' Unit ADIMEM Acquires Membrane Manufacturing Platform from Aquaporin Denmark
Vipul Organics Limited announced that its membrane division, ADIMEM Technologies, has acquired an industrial membrane manufacturing platform from Danish firm Aquaporin via a competitive bidding process. The acquired precision casting, coating, and drying infrastructure will be relocated to ADIMEM's Sayakha facility in Gujarat. This strengthens vertical integration in advanced Reverse Osmosis (RO) and Nanofiltration (NF) membrane manufacturing, expanding beyond traditional dyes and pigments. Total acquisition consideration was not disclosed in the filing.
Confidence: HIGH
What changedADIMEM Technologies acquired an advanced manufacturing platform from Denmark's Aquaporin to manufacture membrane sheets domestically in Sayakha, Gujarat.
Why it mattersAccelerates ADIMEM's high-tech membrane manufacturing capabilities organically without multi-year development lag, diversifying Vipul Organics from standard specialty chemicals into higher-margin water treatment solutions.
Deal acquisition cost: not disclosedFY26 Revenue: Rs 175.4 CroreGlobal footprint: over 50 countries
📅 Short termPositive sentiment on technological capability addition, though market impact will depend on execution and asset relocation timelines.
📈 Long termEnables domestic vertical integration for advanced RO/NF membrane manufacturing, providing a high-growth, sustainability-driven revenue vertical alongside core pigments.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Commercial integration and equipment relocation execution risks
- Acquisition value and expected ROI not disclosed in filing
- High industry competition in water treatment solutions
Key Highlights
Acquired production-grade membrane sheet casting, coating, and drying infrastructure from Aquaporin, Denmark
Asset to be relocated to Vipul's greenfield/expansion site at Sayakha, Gujarat
Strengthens capability across RO, NF, UF, MF, and MBR technologies for industrial water treatment and process separations
Vipul Organics reported FY26 revenue of Rs 175.4 Crore (TTM revenue ~Rs 190 Cr)
Financial deal size and capex outlay was not disclosed
👀 What to Watch
Track the relocation and commercial commissioning timeline at the Sayakha facility, along with membrane revenue contribution in upcoming quarterly disclosures.
Vipul Organics Starts Production at Sayakha Plant; Begins With ~1,800 MT Pigment Capacity
Vipul Organics has commenced commercial production at its greenfield facility in Sayakha, Gujarat. The plant starts with an initial phase output of ~1,800 MT of pigments and has been designed to support over 3,600 MT of annual pigment production. In parallel, the company is consolidating pigment operations from its Tarapur (Maharashtra) site to Sayakha to streamline operations. The 24,633.11 sq. meter integrated facility also houses membrane manufacturing (AdiMem Technologies) near Dahej Port.
Confidence: HIGH
What changedVipul Organics transitioned its Sayakha greenfield facility from construction to commercial production, while beginning the consolidation of its Tarapur pigment manufacturing.
Why it mattersThe site provides substantial room to scale pigment output up to 3,600 MT/year, integrates membrane tech under one roof, and optimizes export logistics through Dahej port proximity.
Initial pigment production: ~1800 MTDesigned annual pigment capacity: ~3,600 MTFacility land area: 24,633.11 sq. mFY26 standalone revenue: Rs. 175.40 crore
📅 Short termPositive operational update marking the start of revenue generation from the greenfield site as production stabilizes.
📈 Long termDoubles potential pigment capacity and unifies dyes, pigments, and membrane operations in a single port-adjacent hub to drive export-led growth.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution and ramp-up timeline risks during initial capacity scale-up
- Potential operational disruptions during migration from Tarapur facility
- Raw material price volatility from crude oil-derived inputs
Key Highlights
Commercial production commenced at greenfield Sayakha facility in Gujarat
Initial production starts at ~1,800 MT of pigments, with designed capacity for ~3,600 MT annually
Pigment production from the Tarapur facility in Maharashtra is being consolidated into Sayakha
Plant spans 24,633.11 sq. meters in GIDC PCPIR, integrating pigment and membrane operations
👀 What to Watch
Track capacity utilization rates, margin improvements from operational consolidation, and revenue ramp-up from the Sayakha facility in upcoming quarterly results.
Vipul Organics Q1 PAT Jumps 99.8% YoY to ₹2.52 Cr; Revenue Up 38.4% to ₹52.18 Cr
Vipul Organics reported a robust 99.75% YoY increase in consolidated net profit to ₹2.52 Cr for Q1 FY26-27, compared to ₹1.26 Cr in the prior year. Total revenue for the quarter grew 38.44% YoY to ₹52.18 Cr, though it declined slightly by 0.85% QoQ from ₹52.62 Cr in Q4. Profit before tax (PBT) surged 113% YoY to ₹3.44 Cr driven by cost optimization and operating leverage. Management confirmed the completion of its current capex cycle and noted that the new membrane division is progressing to provide incremental revenue.
Confidence: HIGH
What changedVipul Organics released its Q1 FY26-27 press release showing strong YoY profit doubling and high double-digit topline growth.
Why it mattersDemonstrates operating leverage and margin recovery following completed capital expenditures and cost rationalization across specialty pigment segments.
Q1 Consolidated Revenue: ₹52.18 CrRevenue Growth (YoY): 38.44%Q1 Consolidated PAT: ₹2.52 CrPAT Growth (YoY): 99.75%Q1 EPS: ₹1.33
📅 Short termThe strong YoY earnings growth and sequential margin improvement may support positive sentiment in the short term.
📈 Long termPost-capex asset utilization and the addition of higher-margin product lines like membranes will dictate medium-to-long term ROCE and profitability expansion.
⚠ Risk flags
- Raw material price sensitivity to crude oil and petrochemical feedstocks (65-70% of costs)
- Slight sequential revenue contraction of 0.85% QoQ
Key Highlights
Consolidated revenue up 38.44% YoY to ₹52.18 Cr (₹5,217.52 Lakh) vs ₹37.69 Cr in Q1 FY25-26
Consolidated PAT nearly doubled (+99.75% YoY) to ₹2.52 Cr vs ₹1.26 Cr in the previous year's quarter
Consolidated PBT surged 113% YoY and 14.53% QoQ to ₹3.44 Cr
Diluted EPS increased 54.65% YoY to ₹1.33 per share from ₹0.86 per share
Management highlighted completion of the capex cycle and upcoming commercialization of the membrane division
👀 What to Watch
Track revenue ramp-up from the newly completed capex and the commercial rollout timeline for the membrane division in subsequent quarterly updates.
Vipul Organics Reappoints MD for 5-Year Term; Proposes MoA Expansion into Membrane Tech
Vipul Organics' Board approved the re-appointment of Mr. Vipul P. Shah as Managing Director for a 5-year term from June 15, 2027 to June 14, 2032, subject to shareholder approval at the 54th AGM. The Board also proposed altering the Memorandum of Association (MoA) object clause to diversify into membrane products, water treatment plants, and environmental engineering systems. Additionally, the ESOP scheme was amended to extend the exercise window from 3 months to 2 years post-vesting across 2,00,000 shares. The company reported zero deviation in preferential issue proceeds, having utilized Rs 17.54 Cr of the Rs 27.54 Cr raised so far, with Rs 10.66 Cr deployed toward the Saykha, Gujarat project.
Confidence: HIGH
What changedApproved the re-appointment of the MD for 5 years starting mid-2027 and initiated an MoA object amendment to enable entry into membrane separation and water treatment solutions.
Why it mattersProvides long-term leadership continuity under the core promoter while laying legal and strategic foundations for business diversification beyond core dyes and pigments.
MD Re-appointment Tenure: 5 years (June 15, 2027 to June 14, 2032)Total Preferential Issue Proceeds: Rs 27.54 CrFunds Utilized as of June 30, 2026: Rs 17.54 CrCapex Deployment at Saykha Project: Rs 10.66 CrESOP Shares Covered: 2,00,000 shares
📅 Short termNeutral trading impact expected as these are structural governance approvals and enabling resolutions pending AGM voting.
📈 Long termDiversification into membrane technologies and industrial wastewater separation could broaden the addressable market, but commercial execution will take several quarters to reflect in revenues.
⚠ Risk flags
- Execution and market-entry risks in newly proposed membrane technology domain
- Input cost sensitivity to petrochemical and crude oil raw material prices
Key Highlights
Re-appointment of Managing Director Vipul P. Shah approved for a 5-year term effective June 15, 2027 to June 14, 2032.
Proposed MoA alteration to enter membrane separation modules, water/wastewater treatment, and zero liquid discharge systems.
VOL ESOS 2022 exercise window extended to up to 2 years from the date of vesting (covering 2,00,000 equity shares).
Utilized Rs 17.54 Cr out of Rs 27.54 Cr preferential issue proceeds, including Rs 10.66 Cr spent on the Saykha, Gujarat manufacturing project.
👀 What to Watch
Track shareholder voting outcomes on the special resolutions at the upcoming 54th AGM and monitor project execution updates for the Saykha greenfield facility.
Vipul Organics Proposes Entry into Membrane Tech, Reports ₹17.54 Cr Fund Utilization
Vipul Organics' Board has approved a proposal to alter its Memorandum of Association (MOA) to diversify into membrane products, water/wastewater treatment plants, and industrial separation systems, subject to AGM approval. The company reported utilization of ₹17.54 Cr out of its ₹27.54 Cr preferential issue proceeds, fully deploying ₹10.66 Cr toward the Saykha greenfield project and ₹6.88 Cr for corporate purposes. An allocation of ₹10.00 Cr earmarked for long-term debt reduction remains unutilized as of June 30, 2026. Additionally, Managing Director Vipul P. Shah was re-appointed for a five-year term starting June 2027, and the ESOP exercise period was extended from 3 months to 2 years.
Confidence: HIGH
What changedThe Board approved diversification into membrane and environmental engineering solutions and reported fund utilization status for the ₹27.54 Cr preferential issue.
Why it mattersExpanding into membrane separation systems opens higher-margin industrial water treatment markets, while commissioning Saykha provides the next leg of manufacturing capacity beyond Maharashtra.
Preferential issue proceeds: ₹27.54 CrSaykha project fund deployed: ₹10.66 CrAllocated for debt repayment: ₹10.00 CrIssue size vs Market cap: ~6.2%ESOP shares covered: 2,00,000 shares
📅 Short termShareholders will vote on the proposed MOA expansion and ESOP scheme amendments at the upcoming 54th AGM.
📈 Long termSuccessful commercialization of the Saykha plant alongside entry into membrane and water engineering could broaden revenue beyond traditional pigment and dye manufacturing.
⚠ Risk flags
- Execution and technology risk associated with entering high-precision membrane and environmental engineering segments
- Raw material vulnerability to crude oil derivatives (65-70% of costs)
Key Highlights
Proposed MOA expansion to enter membrane tech (UF, RO, NF, MBR) and water treatment (ETP, STP, ZLD) businesses
Utilized ₹10.66 Cr towards the Saykha, Gujarat greenfield project from preferential issue proceeds
Allocated ₹10.00 Cr towards long-term debt reduction, pending utilization
Re-appointed MD Vipul P. Shah for a 5-year tenure effective June 15, 2027 to June 14, 2032
Extended ESOS 2022 option exercise window from 3 months to 2 years post-vesting for 2,00,000 shares
👀 What to Watch
Track shareholder approval at the upcoming 54th AGM for the MOA expansion into membrane technologies, along with execution timelines and commercialization updates at the Saykha greenfield site.
Vipul Organics Expands Business Scope to Membrane Tech; Re-appoints MD for 5 Years
Vipul Organics' Board approved an amendment to its Memorandum of Association (MOA) to diversify into membrane products, water/wastewater treatment, and industrial separation systems, subject to shareholder approval at the 54th AGM. The Board also approved the re-appointment of Managing Director Vipul P. Shah for a 5-year term from June 15, 2027 to June 14, 2032. Additionally, the company reported the utilization of ₹17.54 Cr out of ₹27.54 Cr raised via preferential issue, with ₹10.66 Cr deployed into the Sayakha manufacturing project and ₹6.88 Cr for general corporate purposes. The exercise period under the 2,00,000-share ESOS 2022 scheme was also extended from 3 months to 2 years post-vesting.
Confidence: HIGH
What changedThe Board approved widening its business charter to include membrane tech and water treatment solutions, while extending the ESOS exercise window and renewing the MD's tenure.
Why it mattersThe MOA amendment enables the company to diversify beyond traditional dyes and pigments into higher-value separation and environmental engineering markets.
Preferential issue proceeds raised: ₹27,54,39,400Funds utilized for Sayakha project: ₹10,66,39,400Total funds utilized by June 30, 2026: ₹17,54,39,400ESOS shares pool: 2,00,000 sharesMD re-appointment tenure: 5 years (June 15, 2027 to June 14, 2032)
📅 Short termShareholder voting results at the 54th AGM will confirm adoption of the expanded business objects.
📈 Long termEntry into membrane separation and industrial water treatment could diversify revenue streams away from cyclical commodity pigments if successfully commercialized.
⚠ Risk flags
- Execution and technical risks in entering new membrane and wastewater engineering domains
- Pending approval of special resolutions at the 54th AGM
Key Highlights
Proposed MOA alteration to enter membrane separation (UF/MF/NF/RO) and water treatment systems, subject to AGM approval.
Utilized ₹17.54 Cr of ₹27.54 Cr preferential issue proceeds as of June 30, 2026, including ₹10.66 Cr for the Sayakha project.
Re-appointed MD Vipul P. Shah for a 5-year tenure from June 15, 2027 to June 14, 2032.
Extended ESOS 2022 option exercise period from 3 months to 2 years from vesting for 2,00,000 equity shares.
👀 What to Watch
Track shareholder approval at the upcoming 54th AGM for the MOA object clause expansion and monitor subsequent commercial milestones in the membrane technology division.
